Smart nanoparticles, which can respond to biological cues or be guided by them, are
emerging as a promising drug delivery platform for precise cancer treatment. The field of …

Drug delivery technologies have enabled the development of many pharmaceutical
products that improve patient health by enhancing the delivery of a therapeutic to its target …

Biomaterials have evolved from inert materials that lack interaction with the body to
biologically active, instructive materials that host and provide signals to surrounding cells …

The metabolic syndrome is prevalent in developed nations and accounts for the largest
burden of non-communicable diseases worldwide. The metabolic syndrome has direct …

Bacteria are one of the main groups of organisms, which dynamically and closely participate
in human health and disease development. With the integration of chemical biotechnology …

The capability to design microbiomes with predictable functions would enable new
technologies for applications in health, agriculture, and bioprocessing. Towards this goal …

The microbiome is emerging as a key player and driver of cancer. Traditional modalities to
manipulate the microbiome (for example, antibiotics, probiotics and microbiota transplants) …

Cell therapies have emerged as a promising therapeutic modality with the potential to treat
and even cure a diverse array of diseases. Cell therapies offer unique clinical and …

There is much human disadvantage and unmet need in the world, including deficits in basic
resources and services considered to be human rights, such as drinking water, sanitation …

Gut microbes influence tumor development and progression in the intestines and may
provide a novel paradigm for the treatment of colorectal cancer (CRC). Gut dysbiosis may be …